Repligen Corporation (RGEN)
NASDAQ
163.84
-3.38 (-2.02%)
Closed
Oct 8, 2026
Day's Range
157.44164.65
52 wk Range
100.99198.87
Financial Statements - RGEN - Repligen Corporation
Revenue
738.25M▲ 16.4%
Net Income
48.89M▲ 291.6%Net Margin 6.6%
EBITDA
139.67M▲ 193.3%
Free Cash Flow
91.68M▼ 35.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 738.25M | 634.43M | 632.36M | 801.53M | 670.53M | 366.26M |
| Cost of Goods | 352.01M | 359.79M | 353.92M | 345.83M | 279.28M | 156.63M |
| Gross Profit | 386.24M | 274.64M | 278.44M | 455.70M | 391.25M | 209.62M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 41.56M | -31.92M | 17.13M | 195.94M | 173.11M | 69.82M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 43.99M | 27.46M | 50.15M | 26.17M | -6.85M | 1.52M |
| Pre Tax Income | 62.38M | -27.03M | 56.70M | 219.14M | 153.54M | 59.21M |
| Income Tax | 13.48M | -1.52M | 21.11M | 33.18M | 25.25M | -709K |
| Net Income | 48.89M | -25.51M | 35.59M | 185.95M | 128.29M | 59.92M |
| EPS Basic | 0.87 | -0.46 | 0.64 | 3.35 | 2.33 | 1.14 |
| EPS Diluted | 0.86 | -0.46 | 0.63 | 3.24 | 2.24 | 1.11 |
| Basic Shares Outstanding | 56.23M | 55.93M | 55.72M | 55.46M | 55.01M | 52.55M |
| Diluted Shares Outstanding | 56.23M | 55.93M | 55.72M | 55.46M | 55.01M | 52.55M |
| Ebit | 83.89M | -6.30M | 59.21M | 220.30M | 164.82M | 69.98M |
| Ebitda | 139.67M | 47.62M | 85.73M | 235.58M | 208.95M | 95.31M |
| Net Income Continuous Operations | 48.89M | -25.51M | 35.59M | 185.95M | 128.29M | 59.92M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
